Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia
- PMID: 11431691
- DOI: 10.1038/90054
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia
Abstract
t(1;22) is the principal translocation of acute megakaryoblastic leukemias. Here we show this chromosomal rearrangement to result in the fusion of two novel genes, RNA-binding motif protein-15 (RBM15), an RNA recognition motif-encoding gene with homology to Drosophila spen, and Megakaryoblastic Leukemia-1 (MKL1), a gene encoding an SAP (SAF-A/B, Acinus and PIAS) DNA-binding domain.
Similar articles
-
Acute megakaryoblastic leukemia with t(1;22)(p13.3;q13.1); RBM15-MKL1 mimicking hepatoblastoma in an infant: The role of karyotype in differential diagnosis.Pediatr Blood Cancer. 2020 Mar;67(3):e28111. doi: 10.1002/pbc.28111. Epub 2019 Dec 4. Pediatr Blood Cancer. 2020. PMID: 31802626 No abstract available.
-
Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene.Pediatr Blood Cancer. 2011 May;56(5):846-9. doi: 10.1002/pbc.22765. Epub 2011 Jan 13. Pediatr Blood Cancer. 2011. PMID: 21370421
-
MLL-MLLT10 fusion gene in pediatric acute megakaryoblastic leukemia.Leuk Res. 2005 Oct;29(10):1223-6. doi: 10.1016/j.leukres.2005.03.008. Epub 2005 Apr 11. Leuk Res. 2005. PMID: 16111539 Review.
-
RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient.Am J Hematol. 2005 May;79(1):43-5. doi: 10.1002/ajh.20298. Am J Hematol. 2005. PMID: 15849773
-
[Molecular basis of the t(1;22)(p13;q13) specific for human acute megakaryoblastic leukemia].Pathol Biol (Paris). 2003 Feb;51(1):27-32. doi: 10.1016/s0369-8114(02)00354-1. Pathol Biol (Paris). 2003. PMID: 12628289 Review. French.
Cited by
-
MKL-1 suppresses ferroptosis by activating system Xc- and increasing glutathione synthesis.Int J Biol Sci. 2023 Aug 21;19(14):4457-4475. doi: 10.7150/ijbs.80666. eCollection 2023. Int J Biol Sci. 2023. PMID: 37781038 Free PMC article.
-
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.Blood Adv. 2024 Jan 9;8(1):112-129. doi: 10.1182/bloodadvances.2022008899. Blood Adv. 2024. PMID: 37729615 Free PMC article.
-
N6-methyladenosine RNA modifications: a potential therapeutic target for AML.Ann Hematol. 2023 Aug 7. doi: 10.1007/s00277-023-05302-6. Online ahead of print. Ann Hematol. 2023. PMID: 37548690 Review.
-
Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development.Front Cell Dev Biol. 2023 Jun 1;11:1170622. doi: 10.3389/fcell.2023.1170622. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37325571 Free PMC article. Review.
-
RNA modifications in hematological malignancies.Int J Hematol. 2023 Jun;117(6):807-820. doi: 10.1007/s12185-023-03576-0. Epub 2023 Mar 16. Int J Hematol. 2023. PMID: 36929506 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous